COVID-19, Arrhythmic Risk, and Inflammation: Mind the Gap!

Circulation. 2020 Jul 7;142(1):7-9. doi: 10.1161/CIRCULATIONAHA.120.047293. Epub 2020 Apr 14.

Authors

Pietro Enea Lazzerini¹, Mohamed Boutjdir^#^{2

3}, Pier Leopoldo Capecchi^#¹

Affiliations

¹ Department of Medical Sciences, Surgery, and Neurosciences, University of Siena, Italy (P.E.L., P.L.C.).
² VA New York Harbor Healthcare System, SUNY Downstate Medical Center (M.B.).
³ NYU School of Medicine (M.B.).

^# Contributed equally.

PMID: 32286863
DOI: 10.1161/CIRCULATIONAHA.120.047293

No abstract available

Keywords: COVID-19; arrhythmia; inflammation.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents / chemistry
Antiviral Agents / metabolism
Antiviral Agents / therapeutic use
Arrhythmias, Cardiac / etiology
Arrhythmias, Cardiac / pathology*
Betacoronavirus / isolation & purification
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / drug therapy
Coronavirus Infections / pathology*
Coronavirus Infections / virology
Cytochrome P-450 CYP2D6 / chemistry
Cytochrome P-450 CYP2D6 / metabolism
Cytochrome P-450 CYP3A / chemistry
Cytochrome P-450 CYP3A / metabolism
Electrocardiography
Humans
Inflammation
Interleukin-6 / chemistry
Interleukin-6 / metabolism
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / drug therapy
Pneumonia, Viral / pathology*
Pneumonia, Viral / virology
Risk Factors
SARS-CoV-2

Substances

Antiviral Agents
Interleukin-6
Cytochrome P-450 CYP2D6
Cytochrome P-450 CYP3A